Jazz Pharmaceuticals
JAZZ
#1433
Rank
A$22.54 B
Marketcap
A$359.31
Share price
-1.56%
Change (1 day)
102.01%
Change (1 year)

Jazz Pharmaceuticals (JAZZ) - Total assets

Total assets on the balance sheet as of March 2026 : A$16.98 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's total assets are A$16.98 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jazz Pharmaceuticals - Total assets on balance sheet (from 2005 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$17.40 B-9.86%
2024-12-31A$19.31 B15.48%
2023-12-31A$16.72 B5.03%
2022-12-31A$15.92 B-6.14%
2021-12-31A$16.96 B99.58%
2020-12-31A$8.50 B7.44%
2019-12-31A$7.91 B7.1%
2018-12-31A$7.38 B12.55%
2017-12-31A$6.56 B-1.45%
2016-12-31A$6.65 B45.57%
2015-12-31A$4.57 B12.13%
2014-12-31A$4.07 B62.59%
2013-12-31A$2.50 B32.6%
2012-12-31A$1.89 B665.18%
2011-12-31A$0.24 B85.08%
2010-12-31A$0.13 B11.77%
2009-12-31A$0.11 B-28.21%
2008-12-31A$0.16 B-29.85%
2007-12-31A$0.23 B-12.78%
2006-12-31A$0.27 B20.87%
2005-12-31A$0.22 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
A$169.74 B 899.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
A$87.61 B 415.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
A$7.35 B-56.68%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$57.34 B 237.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel